{"id":"https://openalex.org/A5116662873","orcid":null,"observed_orcids":[],"display_name":"Marissa Mazurie","raw_author_names":["Marissa Mazurie"],"full_name":"Marissa Mazurie","works_count":2,"cited_by_count":2,"summary_stats":{"2yr_mean_citedness":1.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5116662873","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I36258959","ror":"https://ror.org/0168r3w48","display_name":"University of California San Diego","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},"years":[2025]}],"last_known_institutions":[{"id":"https://openalex.org/I36258959","ror":"https://ror.org/0168r3w48","display_name":"University of California San Diego","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"topics":[{"id":"https://openalex.org/T12796","display_name":"Dermatological and COVID-19 studies","count":2,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11078","display_name":"Inflammasome and immune disorders","count":1,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","count":1,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","count":1,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","count":1,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12796","display_name":"Dermatological and COVID-19 studies","value":3.83e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","value":2.17e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11078","display_name":"Inflammasome and immune disorders","value":1.1e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","value":6.1e-06,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","value":4.2e-06,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"156662089","wikidata":"https://www.wikidata.org/wiki/Q6931223","display_name":"Mucocutaneous zone","score":0.8526139259338379},{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.5364999771118164},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.5309861302375793},{"id":"2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","score":0.2590999901294708},{"id":"142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","score":0.1367034912109375}],"counts_by_year":[{"year":2025,"works_count":2,"oa_works_count":2,"cited_by_count":0},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":2}],"display_name_alternatives":["Marissa Mazurie"],"block_key":"m mazurie","works_api_url":"https://api.openalex.org/works?filter=author.id:A5116662873","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2025-03-18T00:00:00"}